The Neurokinin 3 Receptor Antagonist, Fezolinetant, is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Fraser, Graeme
  • Lederman, Samuel
  • Waldbaum, Arthur
  • Lee, Misun
  • Skillern, Laurence
  • Ramael, Steven

publication date

  • June 1, 2019